Avingtrans plc has announced that Stuart Gall officially assumed the role of Chief Executive Officer of its medical and industrial imaging division on 1 January 2026...
Avingtrans reported that its subsidiary Adaptix has received FDA 510(k) clearance for the Ortho350, a compact 3D orthopaedic imaging system designed for point of care use...
Avingtrans has delivered record revenue of £156.4 million for FY25, with Chief Executive Officer Steve McQuillan highlighting robust order book growth, major contract wins, and increasing demand across energy, defence, infrastructure and medical divisions...
Avingtrans Plc has announced the appointment of Stuart Gall as Divisional Chief Executive Officer of its medical imaging businesses, including Adaptix and Magnetica, effective on or before 10 March 2026...
Avingtrans CEO Steve McQuillan shares how AI, energy and infrastructure megatrends are driving record results — and why strategic deals could be back on the table in FY26...
Avingtrans posted preliminary results for the year ended 31 May 2025, with revenue up 14.5% to a record £156.4m and adjusted EBITDA rising to £16.7m. Adjusted profit before tax increased 18% to £8.6m, while diluted EPS grew 28% to 23.7p...
Avingtrans’ US subsidiary, Hayward Tyler Inc., has won two contracts worth over $16m from Korea Hydro & Nuclear Power. The deals cover safety-related pumps and spare parts for nuclear reactors in South Korea, with manufacturing in Vermont and delivery scheduled by FY27...
Avingtrans (AIM: AVG) reports strong FY25 results, with revenue and profits in line with upgraded expectations, driven by the Advanced Engineering Systems division...
Avingtrans PLC (LON:AVG) reveals positive trading updates for FY25, expecting to exceed market expectations in Adj. EBITDA, driven by strong performance in Advanced Engineering Systems...
Avingtrans PLC reports strong performance in H1 2024, with expectations aligned across energy, medical, and industrial sectors. Growth anticipated in FY25...
Avingtrans plc's Adaptix, an innovator in 3D X-Ray imaging, wins Aerospace Technology Innovation Award for its breakthrough in non-destructive testing...
Avingtrans plc CEO Steve McQuillan discusses preliminary results for the year ended 31 May 2024, highlighting record sales, strategic acquisitions, and future growth...
Avingtrans PLC (LON:AVG) announces a remarkable 17.3% revenue increase to £136.6m for the year ended 31 May 2024, highlighting strategic investments and robust growth across energy and medical sectors...
Avingtrans PLC (LON:AVG) reports record revenue and adjusted EBITDA ahead of expectations for the financial year ending 31 May 2024, with strong growth across its divisions...
Avingtrans PLC (LON:AVG) announces interim results for Nov 2023, showing a 30.4% revenue increase and 14.1% rise in adjusted EBITDA. Operating highlights include acquisitions and new contracts in various sectors...
Avingtrans plc has announced that Stuart Gall officially assumed the role of Chief Executive Officer of its medical and industrial imaging division on 1 January 2026...
Avingtrans reported that its subsidiary Adaptix has received FDA 510(k) clearance for the Ortho350, a compact 3D orthopaedic imaging system designed for point of care use...
Avingtrans has delivered record revenue of £156.4 million for FY25, with Chief Executive Officer Steve McQuillan highlighting robust order book growth, major contract wins, and increasing demand across energy, defence, infrastructure and medical divisions...
Avingtrans Plc has announced the appointment of Stuart Gall as Divisional Chief Executive Officer of its medical imaging businesses, including Adaptix and Magnetica, effective on or before 10 March 2026...
Avingtrans CEO Steve McQuillan shares how AI, energy and infrastructure megatrends are driving record results — and why strategic deals could be back on the table in FY26...
Avingtrans posted preliminary results for the year ended 31 May 2025, with revenue up 14.5% to a record £156.4m and adjusted EBITDA rising to £16.7m. Adjusted profit before tax increased 18% to £8.6m, while diluted EPS grew 28% to 23.7p...
Avingtrans’ US subsidiary, Hayward Tyler Inc., has won two contracts worth over $16m from Korea Hydro & Nuclear Power. The deals cover safety-related pumps and spare parts for nuclear reactors in South Korea, with manufacturing in Vermont and delivery scheduled by FY27...
Avingtrans (AIM: AVG) reports strong FY25 results, with revenue and profits in line with upgraded expectations, driven by the Advanced Engineering Systems division...
Avingtrans PLC (LON:AVG) reveals positive trading updates for FY25, expecting to exceed market expectations in Adj. EBITDA, driven by strong performance in Advanced Engineering Systems...
Avingtrans PLC reports strong performance in H1 2024, with expectations aligned across energy, medical, and industrial sectors. Growth anticipated in FY25...
Avingtrans plc's Adaptix, an innovator in 3D X-Ray imaging, wins Aerospace Technology Innovation Award for its breakthrough in non-destructive testing...
Avingtrans plc CEO Steve McQuillan discusses preliminary results for the year ended 31 May 2024, highlighting record sales, strategic acquisitions, and future growth...
Avingtrans PLC (LON:AVG) announces a remarkable 17.3% revenue increase to £136.6m for the year ended 31 May 2024, highlighting strategic investments and robust growth across energy and medical sectors...
Avingtrans PLC (LON:AVG) reports record revenue and adjusted EBITDA ahead of expectations for the financial year ending 31 May 2024, with strong growth across its divisions...
Avingtrans PLC (LON:AVG) announces interim results for Nov 2023, showing a 30.4% revenue increase and 14.1% rise in adjusted EBITDA. Operating highlights include acquisitions and new contracts in various sectors...
